Immunocytochemical prognostic markers in pituitary tumors.
The value of different immunocytochemical markers in the evaluation of the pituitary tumor aggressiveness is discussed on the basis of the data from the literature and the author's personal experience. The usefulness of the proliferation markers (PCNA, Ki-67), prothymosin-alpha, the endothelial markers revealing the intratumoral vascularization and of the expression or co-expression of glycoprotein hormones in predicting the aggressive behaviour of the tumor is likely, but still needs further studies.
Pawlikowski
M
M
Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University, Lódź, Poland.
D015415:Biomarkers; D006801:Humans; D007150:Immunohistochemistry; D010907:Pituitary Hormones / Q000378:metabolism; D010911:Pituitary Neoplasms / Q000276:immunology / Q000473:pathology*; D011379:Prognosis
D015415:Biomarkers; D010907:Pituitary Hormones